Check-Cap (CHEK) Competitors $0.73 -0.02 (-2.42%) Closing price 07/3/2025 12:36 PM EasternExtended Trading$0.75 +0.02 (+2.72%) As of 07/3/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock CHEK vs. DRCT, SLGL, CLGN, NRXS, PSTV, NXL, IRIX, MHUA, XAIR, and LYRAShould you be buying Check-Cap stock or one of its competitors? The main competitors of Check-Cap include Direct Digital (DRCT), Sol-Gel Technologies (SLGL), CollPlant Biotechnologies (CLGN), NeurAxis (NRXS), Plus Therapeutics (PSTV), Nexalin Technology (NXL), IRIDEX (IRIX), Meihua International Medical Technologies (MHUA), Beyond Air (XAIR), and Lyra Therapeutics (LYRA). Check-Cap vs. Its Competitors Direct Digital Sol-Gel Technologies CollPlant Biotechnologies NeurAxis Plus Therapeutics Nexalin Technology IRIDEX Meihua International Medical Technologies Beyond Air Lyra Therapeutics Direct Digital (NASDAQ:DRCT) and Check-Cap (NASDAQ:CHEK) are related small-cap companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Which has more volatility and risk, DRCT or CHEK? Direct Digital has a beta of 6.07, suggesting that its share price is 507% more volatile than the S&P 500. Comparatively, Check-Cap has a beta of 0.19, suggesting that its share price is 81% less volatile than the S&P 500. Do institutionals and insiders believe in DRCT or CHEK? 4.0% of Direct Digital shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 62.8% of Direct Digital shares are held by company insiders. Comparatively, 0.5% of Check-Cap shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer DRCT or CHEK? Direct Digital currently has a consensus price target of $6.00, indicating a potential upside of 821.66%. Given Direct Digital's stronger consensus rating and higher probable upside, analysts plainly believe Direct Digital is more favorable than Check-Cap.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Direct Digital 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Check-Cap 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to DRCT or CHEK? In the previous week, Check-Cap had 2 more articles in the media than Direct Digital. MarketBeat recorded 2 mentions for Check-Cap and 0 mentions for Direct Digital. Direct Digital's average media sentiment score of 0.00 equaled Check-Cap'saverage media sentiment score. Company Overall Sentiment Direct Digital Neutral Check-Cap Neutral Which has higher earnings and valuation, DRCT or CHEK? Direct Digital has higher revenue and earnings than Check-Cap. Direct Digital is trading at a lower price-to-earnings ratio than Check-Cap, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDirect Digital$62.29M0.20-$6.24M-$1.76-0.37Check-CapN/AN/A-$17.57M-$3.00-0.24 Is DRCT or CHEK more profitable? Check-Cap has a net margin of 0.00% compared to Direct Digital's net margin of -16.23%. Company Net Margins Return on Equity Return on Assets Direct Digital-16.23% N/A -24.12% Check-Cap N/A N/A N/A SummaryDirect Digital beats Check-Cap on 9 of the 13 factors compared between the two stocks. Get Check-Cap News Delivered to You Automatically Sign up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CHEK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CHEK vs. The Competition Export to ExcelMetricCheck-CapMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.33M$6.86B$5.53B$9.04BDividend YieldN/A1.21%5.24%4.01%P/E Ratio-0.2426.6327.6420.25Price / SalesN/A85.64416.59118.23Price / CashN/A21.0936.8958.07Price / Book0.184.748.035.67Net Income-$17.57M$173.18M$3.18B$249.21M7 Day Performance-4.05%1.33%2.92%3.28%1 Month Performance-9.35%0.16%3.72%5.55%1 Year Performance-63.30%23.71%35.14%21.08% Check-Cap Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CHEKCheck-Cap0.4704 of 5 stars$0.73-2.4%N/A-64.2%$4.33MN/A-0.2480News CoverageDRCTDirect Digital3.5051 of 5 stars$0.57+4.6%$6.00+961.9%-84.7%$10.21M$62.29M-0.3260Gap UpSLGLSol-Gel Technologies2.6439 of 5 stars$7.40+1.1%$40.00+440.5%-17.9%$20.39M$11.54M-1.5750CLGNCollPlant Biotechnologies2.5198 of 5 stars$1.36-1.4%$11.50+745.6%-72.3%$17.55M$510K-1.1170NRXSNeurAxis3.3679 of 5 stars$2.42-2.4%$7.00+189.3%-10.5%$17.46M$2.93M-1.3219News CoverageInsider TradePSTVPlus Therapeutics1.7083 of 5 stars$0.35+10.4%$10.83+3,014.8%-80.7%$16.07M$5.82M-0.1220High Trading VolumeNXLNexalin Technology2.3445 of 5 stars$0.99+7.4%$5.00+406.2%-31.6%$15.80M$170K-1.193Positive NewsIRIXIRIDEX0.5419 of 5 stars$0.88+0.2%N/A-55.7%$14.77M$48.67M-2.05120News CoverageMHUAMeihua International Medical Technologies1.1754 of 5 stars$0.40-11.2%N/A-53.3%$14.36M$96.90M0.00620News CoveragePositive NewsGap DownXAIRBeyond Air3.9239 of 5 stars$0.17+7.7%$1.50+770.6%-69.7%$13.82M$3.70M-0.2270LYRALyra Therapeutics2.2963 of 5 stars$8.96-1.6%$100.00+1,016.1%-35.6%$12.07M$1.53M-0.1550Analyst Upgrade Related Companies and Tools Related Companies DRCT Alternatives SLGL Alternatives CLGN Alternatives NRXS Alternatives PSTV Alternatives NXL Alternatives IRIX Alternatives MHUA Alternatives XAIR Alternatives LYRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CHEK) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Check-Cap Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Check-Cap With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
